NAYA: NAYA Biosciences Inc Company Value to Net Income

NAYA Biosciences Inc - graphic logo of issuer NAYA

NAYA Biosciences (NAYA) is implementing AI bioinformatics and robotics for antibody creation, eliminating the human factor in research. This daily price chart, where the indicator stands at -0.20, highlights the risks of test failures amid fierce competition for capital. Business stability is ensured by a calibrated instrument fleet and the scheduled utilization of sterile zones for biopharmaceutical production.

Price to Earnings Ratio: NAYA Biosciences (NAYA) for 07/04/2022 - 04/28/2025

Comprehensive metric breakdowns and analytics for NAYA Bio (NAYA)

- share price and expert price forecast:
Price Performance Chart nayabiosciences.com|NAYA - Consensus Target
- market capitalization information:
Market Value NAYA Biosciences Inc.|NAYA - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value per Share NAYA Biosciences|NAYA - Company Net Assets|Market Capitalization to Book Value Ratio nayabiosciences.com|NAYA - Aggregate Company Assets
- debt and solvency information:
All Debt to Shareholders' Equity Ratio NAYA Biosciences|NAYA - Long-Term Debt to Capital|Current Liabilities to Capital NAYA Biosciences Corp|NAYA - Company Debts|Debt to Book Value Ratio NAYA Biosciences Inc.|NAYA - Company Long-Term Debts|Company Short-Term Debts NAYA Biosciences|Immediate Liquidity nayabiosciences.com
- company profitability and valuation multiples indicators:
NAYA - Net Profit|Projected Future Earnings NAYA Biosciences|NAYA - Price to Earnings Ratio|Future Price to Earnings Multiple NAYA Biosciences Inc|NAYA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NAYA Biosciences Inc.|NAYA - Operating profit EBITDA|Net earnings per share for the last four quarters NAYA Biosciences|NAYA - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months nayabiosciences.com|NAYA - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year NAYA Biosciences
Comprehensive company analysis:nayabiosciences.com NAYA
Flagship merchandise of NAYA Biosciences Inc.

The P/E ratio determines the market value of a single unit of net profit, reflecting the investment payback period. Analyzing the rolling P/E of a company allows for real-time tracking of this ratio's dynamics. The formula measures the premium the market is willing to pay for current financial results. For NAYA Biosciences (NAYA), this indicator reflects expectations for breakthrough gene modification methods. High values confirm investor confidence in the scientific authority of the biotech brand.

Key competitors

ONC: Company Value to Net Income|Price to Earnings Ratio HALO (Halozyme)|RVMD (Revolution Medicines Inc) - Company Value to Net Income|P/E Multiple AAPG (Ascentage)|CGON - Price to Earnings Ratio|URGN: Price to Earnings Ratio|BCAX - P/E Multiple|Personalis (PSNL) - Price to Earnings Ratio|Erasca Inc - Company Value to Net Income|DCTH (Delcath) - P/E Multiple|Market Cap to Earnings Y-mAbs Corp YMAB|Price to Earnings Ratio Aura Biosciences, Inc. (AURA)|candeltx.com - Price to Earnings Multiple|P/E Multiple ARAY (Accuray)|P/E Multiple SELLAS Life Sciences Group, Inc. SLS|ACTU: Price to Earnings Ratio|Market Cap to Earnings Citius Oncology Inc|HURA: P/E Multiple|protaratx.com (TARA) - P/E Multiple|Price to Earnings Ratio FATE|WHWK: Company Value to Net Income|P/E Multiple TCRX|Price to Earnings Ratio CSBR (championsoncology.com)|P/E Multiple XBIT (XBiotech)|Business Payback Period CEL-SCI Corp. (CVM)|OSTX - Price to Earnings Ratio|Market Cap to Earnings radiopharmtheranostics.com|artivabio.com (ARTV) - Price to Earnings Ratio|ANL - Business Payback Period|VERU (Veru Inc.) - P/E Multiple|Price to Earnings Ratio tempesttx.com (TPST)|P/E Multiple XLO|Business Payback Period renovarobio.com|P/E Multiple MURA (Mural Oncology)|Kairos Pharma Limited (KAPA) - Market Cap to Earnings|OKUR - Price to Earnings Ratio|GDTC (CytoMed Therapeutics) - Price to Earnings Multiple|CRIS: P/E Multiple|Price to Earnings Ratio Apollomics|THAR (Tharimmune Corp) - P/E Multiple|Market Cap to Earnings Advanced Biomed Corp ADVB|Price to Earnings Ratio Genprex, Inc. (GNPX)|Business Payback Period calidibio.com|Price to Earnings Ratio Sunshine Biopharma, Inc. SBFM|XBIO: Price to Earnings Multiple|Salarius - P/E Multiple|PPBT - P/E Multiple|AONC (aoncology.com) - Price to Earnings Ratio|Market Cap to Earnings beigene.com (BGNE)|CKPT (Checkpoint Therapeutics, Inc.) - P/E Multiple|P/E Multiple elevationoncology.com|P/E Multiple ICAD|Price to Earnings Ratio ikenaoncology.com IKNA|P/E Multiple NTBL (Notable Labs, Ltd.)|P/E Multiple Viracta Therapeutics Inc. VIRX|MOR - Price to Earnings Ratio|AAPGV (Ascentage Pharma Group International) - Price to Earnings Multiple